{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:02:42Z","timestamp":1758632562460,"version":"3.32.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.clinthera.2005.11.002","type":"journal-article","created":{"date-parts":[[2005,12,22]],"date-time":"2005-12-22T23:48:05Z","timestamp":1135295285000},"page":"1834-1846","source":"Crossref","is-referenced-by-count":24,"title":["Evaluation of the cost-effectiveness of Sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom"],"prefix":"10.1016","volume":"27","author":[{"given":"Phil","family":"McEwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keshwar","family":"Baboolal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pete","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig J.","family":"Currie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2005.11.002_bib1","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1046\/j.1523-1755.2003.00289.x","article-title":"Health-related quality of life among dialysis patients on three continents: The Dialysis Outcomes and Practice Patterns Study","volume":"64","author":"Fukuhara","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2005.11.002_bib2","first-page":"352","article-title":"Results of 25 years of kidney transplantation [in French]","volume":"34","author":"Pastural","year":"2000","journal-title":"Ann Urol (Paris)"},{"key":"10.1016\/j.clinthera.2005.11.002_bib3","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1600-6143.2004.00484.x","article-title":"Surrogate markers for longterm renal allograft survival","volume":"4","author":"Hariharan","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.clinthera.2005.11.002_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1017\/S026646230000876X","article-title":"Cost-effectiveness studies of renal transplantation","volume":"11","author":"Karlberg","year":"1995","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.clinthera.2005.11.002_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7182\/prtr.11.1.5235m177144q114j","article-title":"Use of sirolimus in kidney transplantation","volume":"1","author":"Podbielski","year":"2001","journal-title":"Prog Transplant"},{"key":"10.1016\/j.clinthera.2005.11.002_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ndt\/16.1.18","article-title":"Sirolimus: A new promising immunosuppressive drug. Towards a rationale for its use in renal transplantation","volume":"16","author":"Morelon","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2005.11.002_bib7","first-page":"1185","article-title":"Aspects of cyclosporine A toxicity in the development of coronary artery disease in transplant recipients","volume":"34","author":"Hennersdorf","year":"2002"},{"key":"10.1016\/j.clinthera.2005.11.002_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev.me.37.020186.001243","article-title":"Action and toxicity of cyclosporine","volume":"37","author":"Bennett","year":"1986","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.clinthera.2005.11.002_bib9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/qjmed\/hcg072","article-title":"The evolving role of sirolimus in renal transplantation","volume":"96","author":"Dupont","year":"2003","journal-title":"Qjm"},{"key":"10.1016\/j.clinthera.2005.11.002_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00041552-200211000-00006","article-title":"Sirolimus (Rapamune) in renal transplantation","volume":"11","author":"Johnson","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.clinthera.2005.11.002_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1358\/dot.2001.37.6.627958","article-title":"Combination treatment with sirolimus and cyclosporin in clinical renal transplantation: A comprehensive review","volume":"37","author":"Yoo","year":"2001","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.clinthera.2005.11.002_bib12","first-page":"771A","article-title":"Impact on renal function in kidney transplant recipients with cyclosporine\/tacrolimus toxicity after conversion to Sirolimus","volume":"13","author":"Kashif","year":"2002","journal-title":"J Am Soc Nephrology"},{"key":"10.1016\/j.clinthera.2005.11.002_bib13","first-page":"687","article-title":"The application, mechanism of action and side-effects of immunosuppressive agents in clinical transplantation","volume":"70","author":"du Toit","year":"1986","journal-title":"S Afr Med J"},{"year":"2003","series-title":"Fact sheet: Transplantation cost effectiveness [press release]","key":"10.1016\/j.clinthera.2005.11.002_bib14"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2005.11.002_bib15","first-page":"A217","article-title":"The epidemiology of renal transplantation over 34-years to 2000 in Cardiff in people with and without diabetes: A retrospective analysis","volume":"51","author":"McEwan","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2005.11.002_bib16","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1185\/030079905X65574","article-title":"The patterns of graft and patient survival following renal transplanta tion and evaluation of serum creatinine as a predictor of survival: A reviewof data collected from one clinical centre over 34 years","volume":"21","author":"McEwan","year":"2005","journal-title":"Curr Med Res Opin"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2005.11.002_bib17","first-page":"662","article-title":"Effect of the immunosuppressive treatment on long-term renal graft survival","volume":"19","author":"Gonzalez Molina","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2005.11.002_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post-transplant renal function in the first year predicts long term kidney transplant survival","volume":"62","author":"Hariharan","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2005.11.002_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2796.1991.tb00327.x","article-title":"Serum creatinine: An independent predictor of survival after stroke","volume":"229","author":"Friedman","year":"1991","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinthera.2005.11.002_bib20","first-page":"551","article-title":"Preoperative serum creatinine as a predictor of survival in perforated gastroduodenal ulcer","volume":"51","author":"Ferrara","year":"1985","journal-title":"Am Surg"},{"key":"10.1016\/j.clinthera.2005.11.002_bib21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00007890-200009150-00009","article-title":"Evaluation of the older cadaveric kidney donor: The impact of donor hypertension and creatinine clearance on graft performance and survival","volume":"70","author":"Carter","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.clinthera.2005.11.002_bib22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1399-0012.1994.tb00262.x","article-title":"Outcome statistics of renal transplants with an emphasis on long-term survival","volume":"8","author":"Cecka","year":"1994","journal-title":"Clin Transplant"},{"key":"10.1016\/j.clinthera.2005.11.002_bib23","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/00007890-199611150-00009","article-title":"Determinants of chronic renal allograft rejection in cyclosporine treated recipients","volume":"62","author":"Flechner","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.clinthera.2005.11.002_bib24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1053-2498(00)00442-3","article-title":"Even slightly impaired kidney function (creatinine >1.79 mmol\/L) one year after cardiac transplantation has a negative impact on long term survival","volume":"20","author":"Zuckermann","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.clinthera.2005.11.002_bib25","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/00007890-199404150-00015","article-title":"Should hepatitis C-infected kidneys be transplanted in the United States?","volume":"57","author":"Kiberd","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.clinthera.2005.11.002_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.1996.307","article-title":"A study of the quality of life and cost-utility of renal transplantation","volume":"50","author":"Laupacis","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2005.11.002_bib27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF01593889","article-title":"Health-related quality of life in endstage renal failure","volume":"4","author":"Gudex","year":"1995","journal-title":"Qual Life Res"},{"year":"2003","series-title":"British National Formulary","key":"10.1016\/j.clinthera.2005.11.002_bib28"},{"year":"2004","series-title":"Guide to the Methods of Technology Appraisement","key":"10.1016\/j.clinthera.2005.11.002_bib29"},{"key":"10.1016\/j.clinthera.2005.11.002_bib30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/01.TP.0000074360.62032.39","article-title":"Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-Year results of the Rapamune Maintenance Regimen Study","volume":"76","author":"Oberbauer","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.clinthera.2005.11.002_bib31","first-page":"1292","article-title":"Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients","volume":"35","author":"Citterlo","year":"2003"},{"key":"10.1016\/j.clinthera.2005.11.002_bib32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1034\/j.1600-6143.2002.20507.x","article-title":"Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients","volume":"2","author":"Morales","year":"2002","journal-title":"Am J Transplant."},{"key":"10.1016\/j.clinthera.2005.11.002_bib33","first-page":"3234","article-title":"Conversion to rapamycin in renal allograft recipients with biopsy proven calcineurin inhibitor-induced nephrotoxicity","volume":"33","author":"Diekmann","year":"2001"},{"key":"10.1016\/j.clinthera.2005.11.002_bib34","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/01.TP.0000063703.32564.3B","article-title":"A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (Rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients","volume":"75","author":"Baboolal","year":"2003","journal-title":"Transplantation"},{"year":"2004","series-title":"Guide to the Methods of Technology Appraisal","key":"10.1016\/j.clinthera.2005.11.002_bib35"},{"key":"10.1016\/j.clinthera.2005.11.002_bib36","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/01.TP.0000090865.20886.B7","article-title":"Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen","volume":"76","author":"Irish","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.clinthera.2005.11.002_bib37","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00007890-200003150-00028","article-title":"Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation","volume":"69","author":"Johnson","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.clinthera.2005.11.002_bib38","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1097\/01.ASN.0000095250.92361.D5","article-title":"Long-term graft survival with neoral and tacrolimus: A paired kid ney analysis","volume":"14","author":"Kaplan","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2005.11.002_bib39","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1097\/01.TP.0000069831.76067.22","article-title":"Randomized trial of tacrolimus+ mycophenolate mofetil or azathio prine versus cyclosporine + mycophenolate mofetil after cadaveric kidneytransplantation: Results at three years","volume":"75","author":"Gonwa","year":"2003","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2005.11.002_bib40","doi-asserted-by":"crossref","first-page":"i7","DOI":"10.1093\/ndt\/gfg1028","article-title":"Tacrolimusversus cyclosporin immunosuppression: Longterm outcome in renal transplanta tion","volume":"18","author":"Jurewicz","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2005.11.002_bib41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.TP.0000079965.62765.1A","article-title":"Graft survival following livingdonor renal transplantation: A comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids","volume":"76","author":"Bunnapradist","year":"2003","journal-title":"Transplantation"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929180500281X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929180500281X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T19:07:29Z","timestamp":1736190449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929180500281X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S014929180500281X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2005.11.002","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}